US4166452A
(en)
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
US6893625B1
(en)
|
1986-10-27 |
2005-05-17 |
Royalty Pharma Finance Trust |
Chimeric antibody with specificity to human B cell surface antigen
|
EP0291194B8
(en)
|
1987-04-27 |
2003-10-22 |
Inverness Medical Switzerland GmbH |
Immunoassays and devices therefor
|
US5120643A
(en)
|
1987-07-13 |
1992-06-09 |
Abbott Laboratories |
Process for immunochromatography with colloidal particles
|
AU2684488A
(en)
|
1988-06-27 |
1990-01-04 |
Carter-Wallace, Inc. |
Test device and method for colored particle immunoassay
|
US5252496A
(en)
|
1989-12-18 |
1993-10-12 |
Princeton Biomeditech Corporation |
Carbon black immunochemical label
|
US5587458A
(en)
|
1991-10-07 |
1996-12-24 |
Aronex Pharmaceuticals, Inc. |
Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
|
PT582368E
(pt)
|
1992-05-29 |
2001-05-31 |
Lilly Co Eli |
Derivados de tienobenzodiazepina para o tratamento de doencas de cns
|
US6034078A
(en)
|
1992-05-29 |
2000-03-07 |
Eli Lilly And Company Limited |
Thienobenzodiazepine compounds
|
US5527709A
(en)
|
1992-06-26 |
1996-06-18 |
Johnson & Johnson Clinical Diagnostics, Inc. |
Immunoassays with labeled thyronine hapten analogues
|
US5642870A
(en)
|
1992-08-05 |
1997-07-01 |
Sargis; Ike |
Switch stand
|
US5395933A
(en)
|
1992-08-07 |
1995-03-07 |
Eastman Kodak Company |
Carbamazepine hapten analogues
|
JPH07247271A
(ja)
|
1994-01-21 |
1995-09-26 |
Otsuka Pharmaceut Co Ltd |
3,4−ジヒドロカルボスチリル誘導体
|
CA2192467C
(en)
*
|
1994-06-10 |
2009-03-31 |
Alireza Rezaie |
Calcium binding recombinant antibody against protein c
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
US5761894A
(en)
|
1996-09-25 |
1998-06-09 |
Magic Circle Corporation |
Grass striping attachment for lawn mowers
|
US6986890B1
(en)
*
|
1996-11-21 |
2006-01-17 |
Kyowa Hakko Kogyo Co., Ltd. |
Anti-human VEGF receptor Flt-1 monoclonal antibody
|
US6139800A
(en)
|
1997-06-23 |
2000-10-31 |
Luminex Corporation |
Interlaced lasers for multiple fluorescence measurement
|
US6830731B1
(en)
|
1998-01-05 |
2004-12-14 |
Biosite, Inc. |
Immunoassay fluorometer
|
US6541669B1
(en)
|
1998-06-08 |
2003-04-01 |
Theravance, Inc. |
β2-adrenergic receptor agonists
|
US20030143233A1
(en)
|
1999-06-07 |
2003-07-31 |
Neorx Corporation |
Streptavidin expressed gene fusions and methods of use thereof
|
UA76708C2
(uk)
|
1999-12-08 |
2006-09-15 |
Сінгента Патисипейшонс Аг |
Антитіло, яке застосовується в імунологічному аналізі зразка для визначення неонікотиноїдного інсектициду, білковий кон'югат для одержання антитіла, спосіб визначення концентрації неонікотиноїдного інсектициду в зразку та набір для визначення кількості неонікотиноїдного інсектициду
|
US7163681B2
(en)
|
2000-08-07 |
2007-01-16 |
Centocor, Inc. |
Anti-integrin antibodies, compositions, methods and uses
|
US6958156B2
(en)
|
2000-12-15 |
2005-10-25 |
Vyrex Corporation |
Isoflavone derivatives
|
US20030202975A1
(en)
|
2002-02-21 |
2003-10-30 |
Tedder Thomas F. |
Reagents and treatment methods for autoimmune diseases
|
EP2316468A1
(en)
|
2002-02-22 |
2011-05-04 |
Shire LLC |
Delivery system and methods for protecting and administering dextroamphetamine
|
IL163852A0
(en)
|
2002-03-01 |
2005-12-18 |
Immunomedics Inc |
Rs7 antibodies
|
DE60318030T2
(de)
|
2002-03-28 |
2008-04-10 |
Eli Lilly And Co., Indianapolis |
Piperazine-substituierte aryl-benzodiazepine und ihre verwendung als dopaminrezeptor-antagonisten zur behandlung von psychosen
|
SE0201738D0
(sv)
|
2002-06-07 |
2002-06-07 |
Aamic Ab |
Micro-fluid structures
|
JP2005538108A
(ja)
|
2002-07-29 |
2005-12-15 |
ポトマック, ファーマ, エルエルシー |
α−2アドレナリン作動性レセプターアンタゴニストと非定型抗精神病薬精神安定薬との抗精神病薬組み合わせ治療および組成物
|
PT1546134E
(pt)
|
2002-08-05 |
2007-08-10 |
Lilly Co Eli |
''arilbenzodiazepinas substituídas com piperazina''
|
NZ568403A
(en)
|
2003-05-09 |
2009-10-30 |
Univ Duke |
CD20-specific antibodies and methods of employing same
|
BRPI0413555A
(pt)
|
2003-08-18 |
2006-10-17 |
Lundbeck & Co As H |
composto ou sal do mesmo, composição farmacêutica, uso de um composto ou sal, e, método para o tratamento de uma doença, para a fabricação de um composto e para a preparação de composto
|
DE602004024798D1
(de)
|
2003-09-23 |
2010-02-04 |
Fermion Oy |
Herstellung von quetiapin
|
AU2004278414B2
(en)
|
2003-10-01 |
2012-05-24 |
Adolor Corporation |
Spirocyclic heterocyclic derivatives and methods of their use
|
CA2548164C
(en)
|
2003-12-12 |
2013-10-08 |
Inverness Medical Switzerland Gmbh |
Assay kit for detecting analytes of interest in samples
|
SE0400662D0
(sv)
|
2004-03-24 |
2004-03-24 |
Aamic Ab |
Assay device and method
|
EP1748070A4
(en)
|
2004-04-26 |
2007-07-18 |
Takami Matsuyama |
THERAPEUTIC WITH MONOCLONAL ANTIBODY AGAINST FOLAT RECEPTOR BETA (FR-BETA)
|
SE527036C2
(sv)
|
2004-06-02 |
2005-12-13 |
Aamic Ab |
Analysanordning med reglerat flöde och motsvarande förfarande
|
TW200616604A
(en)
|
2004-08-26 |
2006-06-01 |
Nicholas Piramal India Ltd |
Nitric oxide releasing prodrugs containing bio-cleavable linker
|
US7658991B2
(en)
*
|
2004-10-21 |
2010-02-09 |
University Of Georgia Research Foundation, Inc. |
Structures having aligned nanorods and methods of making
|
US7837726B2
(en)
*
|
2005-03-14 |
2010-11-23 |
Abbott Laboratories |
Visible endoprosthesis
|
US20070255094A1
(en)
*
|
2005-03-14 |
2007-11-01 |
Oepen Randolf V |
Crack/fatigue resistant endoprosthesis
|
US20060235005A1
(en)
*
|
2005-04-14 |
2006-10-19 |
Oak Labs, Corp. |
Use of phosphodiesterase 5 (PDE5) inhibitors in the treatment of schizophrenia
|
ZA200708857B
(en)
*
|
2005-04-22 |
2009-01-28 |
Genentech Inc |
Method for treating dementia or alzheimer's disease with a CD30 antibody
|
SE529254C2
(sv)
|
2005-06-17 |
2007-06-12 |
Aamic Ab |
Optiskt testsystem
|
SE528233C2
(sv)
|
2005-06-20 |
2006-09-26 |
Aamic Ab |
Metod och medel för att åstadkomma vätsketransport
|
EP1933814A2
(en)
|
2005-09-15 |
2008-06-25 |
Elan Pharma International Limited |
Nanoparticulate aripiprazole formulations
|
SE529711C2
(sv)
|
2006-03-22 |
2007-11-06 |
Aamic Ab |
Fluorescensläsare
|
US8975374B2
(en)
|
2006-10-20 |
2015-03-10 |
Chugai Seiyaku Kabushiki Kaisha |
Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient
|
ES2405364T3
(es)
|
2006-12-29 |
2013-05-30 |
Abbott Laboratories |
Ensayo diagnóstico para la detección de una molécula o fármaco en sangre entera
|
EP2198309A1
(en)
|
2007-09-27 |
2010-06-23 |
Novartis Ag |
Drug monitoring assay
|
US8133743B2
(en)
|
2007-10-19 |
2012-03-13 |
Roche Diagnostics Operations, Inc. |
Phenobarbital derivatives useful in immunoassay
|
EP3338796A1
(en)
|
2008-07-21 |
2018-06-27 |
Probiodrug AG |
Diagnostic antibody assay
|
AU2009279372A1
(en)
|
2008-08-06 |
2010-02-11 |
Gosforth Centre (Holdings) Pty Ltd |
Compositions and methods for treating psychiatric disorders
|
US20100069356A1
(en)
|
2008-09-17 |
2010-03-18 |
Auspex Pharmaceuticals, Inc. |
Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
|
EA201100613A1
(ru)
|
2008-10-14 |
2011-12-30 |
Астразенека Аб |
Конденсированные, спироциклические гетероароматические соединения для лечения бактериальных инфекций
|
JP2012507297A
(ja)
|
2008-10-29 |
2012-03-29 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Erbb4遺伝子の多型に基づく精神病及び統合失調症の治療法
|
EP2194048A1
(en)
|
2008-12-02 |
2010-06-09 |
Dirk Sartor |
Nitrate esters for the treatment of vascular and metabolic diseases
|
US8480333B2
(en)
|
2008-12-26 |
2013-07-09 |
Steven Edward DeMay |
Frame rail assemblies and interlocking frame rail systems
|
US20100203129A1
(en)
|
2009-01-26 |
2010-08-12 |
Egalet A/S |
Controlled release formulations with continuous efficacy
|
EP3138854B1
(en)
*
|
2009-03-10 |
2022-01-26 |
Baylor Research Institute |
Antibodies against cd40
|
WO2010151711A1
(en)
|
2009-06-25 |
2010-12-29 |
Alkermes, Inc. |
Prodrugs of nh-acidic compounds
|
LT2459220T
(lt)
|
2009-07-31 |
2020-12-28 |
Ascendis Pharma A/S |
Biologiškai suyrantys vandenyje netirpūs hidrogeliai polietilenglikolio pagrindu
|
US8076097B2
(en)
|
2009-08-19 |
2011-12-13 |
Saladax Biomedical Inc. |
Imatinib immunoassay
|
EP2485767A1
(en)
|
2009-10-06 |
2012-08-15 |
Ascendis Pharma A/S |
Carrier linked paliperidone prodrugs
|
US8715699B2
(en)
|
2009-12-31 |
2014-05-06 |
Kempharm, Inc. |
Amino acid conjugates of quetiapine, process for making and using the same
|
LT2544536T
(lt)
|
2010-03-11 |
2019-02-25 |
Kempharm, Inc. |
Kvetiapino riebalų rūgšties konjugatai, jų gamybos būdas ir panaudojimas
|
US8088594B2
(en)
|
2010-03-16 |
2012-01-03 |
Saladax Biomedical Inc. |
Risperidone immunoassay
|
CN102260290A
(zh)
|
2010-05-25 |
2011-11-30 |
苏州波锐生物医药科技有限公司 |
喹喏啉酮类化合物及其在制备精神病药物中的用途
|
WO2011159537A2
(en)
|
2010-06-15 |
2011-12-22 |
The Regents Of The University Of California |
Method and device for analyte detection
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
WO2011163594A2
(en)
|
2010-06-24 |
2011-12-29 |
Alkermes, Inc. |
Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
|
WO2012003418A2
(en)
|
2010-07-02 |
2012-01-05 |
The University Of North Carolina At Chapel Hill |
Functionally selective ligands of dopamine d2 receptors
|
US8623324B2
(en)
|
2010-07-21 |
2014-01-07 |
Aat Bioquest Inc. |
Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
|
AU2012296950B2
(en)
|
2011-08-12 |
2016-09-22 |
Ascendis Pharma A/S |
Polymeric hyperbranched carrier-linked prodrugs
|
WO2013024047A1
(en)
|
2011-08-12 |
2013-02-21 |
Ascendis Pharma A/S |
High-loading water-soluble carrier-linked prodrugs
|
NZ722096A
(en)
|
2011-12-15 |
2016-11-25 |
Alkermes Pharma Ireland Ltd |
Prodrugs of secondary amine compounds
|
MX2015002036A
(es)
|
2012-08-16 |
2016-01-22 |
Janssen Pharmaceutica Nv |
Pirazoles sustituidos como bloqueadores del canal de calcio tipo n.
|
CN104736566A
(zh)
|
2012-08-21 |
2015-06-24 |
奥索临床诊断有限公司 |
帕潘立酮半抗原的抗体及其用途
|
JP6131500B2
(ja)
|
2012-08-21 |
2017-05-24 |
ヤンセン ファーマシューティカ エヌ.ベー. |
リスペリドン及びパリペリドンのハプテン
|
PL3462173T3
(pl)
|
2012-08-21 |
2021-08-16 |
Janssen Pharmaceutica Nv |
Przeciwciała przeciwko rysperydonowi i ich zastosowanie
|
JP6270845B2
(ja)
|
2012-08-21 |
2018-01-31 |
ヤンセン ファーマシューティカ エヌ.ベー. |
アリピプラゾールに対する抗体及びその使用
|
PT2887952T
(pt)
|
2012-08-21 |
2019-08-30 |
Janssen Pharmaceutica Nv |
Anticorpos para haptenos da olanzapina e suas utilizações
|
WO2014031584A1
(en)
|
2012-08-21 |
2014-02-27 |
Janssen Pharmaceutica Nv |
Haptens of aripiprazole and their use in immunoassays
|
CN106928369B
(zh)
|
2012-08-21 |
2021-04-02 |
奥索临床诊断有限公司 |
喹硫平的抗体及其用途
|
JP6131415B2
(ja)
|
2012-08-21 |
2017-05-24 |
ヤンセン ファーマシューティカ エヌ.ベー. |
イムノアッセイに使用するためのクエチアピンのハプテン
|
PT2888258T
(pt)
|
2012-08-21 |
2019-08-21 |
Janssen Pharmaceutica Nv |
Hapteno de paliperidona
|
PL2888284T3
(pl)
|
2012-08-21 |
2023-02-27 |
Janssen Pharmaceutica Nv |
Przeciwciała przeciwko haptenom rysperydonu i ich zastosowanie
|
CN104736567B
(zh)
|
2012-08-21 |
2019-09-03 |
詹森药业有限公司 |
阿立哌唑半抗原的抗体及其用途
|
EP2888590B1
(en)
|
2012-08-21 |
2020-07-08 |
Janssen Pharmaceutica NV |
Antibodies to olanzapine and use thereof
|
EP2888277A4
(en)
|
2012-08-21 |
2016-05-18 |
Ortho Clinical Diagnostics Inc |
ANTIBODIES AGAINST PALIPERIDONE AND USE THEREOF
|
ES2701062T3
(es)
|
2012-08-21 |
2019-02-20 |
Janssen Pharmaceutica Nv |
Haptenos de olanzapina
|
ES2664952T3
(es)
|
2012-08-21 |
2018-04-24 |
Janssen Pharmaceutica Nv |
Anticuerpos para haptenos de quetiapina y uso de los mismos
|
US9453002B2
(en)
|
2013-08-16 |
2016-09-27 |
Janssen Pharmaceutica Nv |
Substituted imidazoles as N-type calcium channel blockers
|